Marijuana

COMMENTARY: How Booming Israeli Weed Industry Is Changing American Pot

Is this just about ‘medical marijuana’? Wasn’t a Jew named David Sassoon protected by Britain’s Rothschild the one to force the introduction of opium to China by bringing death and destruction to millions that still plagues Asia to this day?

Marijuana
“How Booming Israeli Weed Industry Is Changing American Pot,” Source:

Over the past 50 years, Israel has become the epicenter of medical pot. Home to Raphael Mechoulam, the pioneer of marijuana research, Israel is where THC and the endocannabinoid system were first discovered. And with the world’s largest number of clinical trials testing the benefits of medicinal cannabis, Israel has become the global destination for medical cannabis research and development. Now it is becoming the offshore greenhouse for American cannabis companies seeking to overcome the federal roadblocks standing in their way.

Israel was among the first countries to legalize medicinal use and is one of just three countries with a government-supported medical cannabis program. Though recreational use remains illegal, support for legalization is a bipartisan issue, with some of the most outspoken proponents coming from the right. Until now, Israel’s role in this multi-billion dollar field has been limited to R&D. Yet now that the Israeli government has approved the export of medicinal cannabis products, companies there are hoping to gain a larger piece of the market. While importing cannabis into the United States is illegal under federal law, companies can get around that ban by receiving drug approval from the FDA – and that is exactly what Israeli companies hope to do. According to the FDA, nothing is stopping them, as long as they meet the agency’s arduous requirements for drug approval.

While the FDA has approved three drugs containing synthetic cannabinoids (Marinol, Syndros, and Cesamet, which treat symptoms of AIDS and chemotherapy), it has never approved a product derived from botanical marijuana. According to the agency’s guidelines, “Study of marijuana in clinical trial settings is needed to assess the safety and effectiveness of marijuana for medical use.” Yet initiating clinical trials on U.S. soil is difficult to the point of being nearly impossible. So, American companies are increasingly taking a shortcut: beginning phases 1 and 2 of their clinical trials in Israel, after which they will complete phase 3 in the U.S., speeding up the process through which they can apply for FDA approval of the botanical cannabis drugs they are developing.

Though this level of American R&D in Israel is new, Israel’s impact on the American cannabis industry is not. The very fact that medical marijuana is now legal in 29 U.S. states and counting, is a direct result of Israeli research, which essentially legitimized the study of cannabis in the international scientific community that had long stigmatized it. Without this research, “We wouldn’t have the scientific interest we have now around the world,” says Paul Armentano, deputy director of the D.C.-based National Organization for the Reform of Marijuana Laws (NORML). “That really opened the door to making the study of cannabis and cannabinoids a legitimate avenue for more conventional scientists and researchers.”

“The seriousness with which the Israeli scientific community approaches this is incomparable,” says Charles Pollack, director of the Lambert Center for the Study of Medicinal Cannabis at Thomas Jefferson University in Philadelphia. “Israel is a hotbed of quality cannabis research, because they have a much more favorable regulatory climate for doing serious scientific research on medical cannabis.”

Israel is becoming the offshore greenhouse for American cannabis companies seeking to overcome the federal roadblocks.

The Lambert Center is one of several American institutions that have partnered with BOL, collaborating on at least one of the more than 50 clinical trials the Israeli company will begin once its new facility is fully operational in late September. Of the 15 international companies that have already signed up to conduct their R&D at BOL’s facility, at least six are American, and Gedo is in talks with more.

BOL isn’t the only Israeli cannabis company benefitting from international interest. A growing number of American investors are getting on the Israeli cannabis wagon, which they see as the best vehicle for transforming the medical cannabis field, still in its infancy, into a pharmaceutical-level industry.

According to Saul Kaye, the founder of iCAN, an Israeli cannabis R&D firm, 2016 saw the investment of more than $250 million in Israeli cannabis companies and startups – half of that investment camefrom North America. Kaye predicts that investment will grow ten-fold over the next two years, reaching $1 billion. At least 50 American cannabis companies – and counting – have established R&D operations in Israel.

Israel’s journey to the forefront of the medical cannabis field began with 86-year-old Israeli chemist Raphael Mechoulam, known in the field as the Grandfather of Medical Marijuana. In 1963, as a young researcher, Mechoulam secured 11 pounds of Lebanese hashish, which had been confiscated by his friend at a police station in Tel Aviv. He used that hash to identify, isolate and synthesize THC, the psychoactive compound in cannabis, for the first time in history, and study its medical uses. He was also the first to decode the structure of CBD, the plant’s primary non-psychoactive ingredient. But Mechoulam’s most groundbreaking discovery came in 1992, when he and his team at Hebrew University in Jerusalem discovered the physical reason humans can get high.

“It turned out that the cannabinoids in the plant actually mimic the compounds that we form in our brain,” says Mechoulam, a professor and researcher at Hebrew University who works with several American cannabis companies. He and his team discovered that THC triggers the human body’s largest receptor system, now known as the endocannabinoid system, and that the human brain produces its own cannabinoids – compounds that stimulate the body almost exactly the way THC does.

While Mechoulam’s research is what first placed Israel on the medical marijuana map, the country’s progressive attitudes toward cannabis, coupled with the Israeli government’s liberal regulatory policies and the nation’s technological leadership, are what have maintained Israel’s status as the capital of medical marijuana research and development. It might also help that Israel has the world’s highest ratio of marijuana users, according to Israel’s Anti-Drug Authority, with 27 percent of the population aged 18-65 having used marijuana in the last year. That rate is followed by Iceland and the U.S., at 18 and 16 percent respectively.

While the Israeli government invests millions of dollars in medical cannabis research, the U.S. government makes the same research nearly impossible.

“There are onerous restrictions on conducting this research in the U.S. that don’t exist in Israel,” says one expert.

Despite the fact that 95 percent of the U.S. population lives in states where cannabis is legal in some form, marijuana remains federally illegal. This policy makes conducting research into the medical benefits of marijuana notoriously difficult on U.S. soil. Researchers who wish to do so must go through the DEA, the FDA and the National Institute on Drug Abuse (NIDA). Even when American researchers are given approval, they have only one source for their material: a cannabis farm at the University of Mississippi, operated by NIDA. The process, if successful, can take years.

“There’s a lengthy and arduous regulatory process for getting approval for doing studies, and limited resources at these agencies for processing those requests,” says Pollack, of Thomas Jefferson University. “It’s deliberately made very difficult for us.” In Israel, on the other hand, a cannabis clinical trial can get off the ground in a matter of months.

“I think they have approached the issue in a more even-handed and genuine way than the U.S. government has,” says Armentano of NORML. “There are onerous restrictions on conducting this research in the U.S. that don’t exist in Israel.”

This is precisely why many American researchers from universities and private companies are using Israel as an offshore research hub. For example, Pollack, from Thomas Jefferson University, will be conducting clinical trials at BOL’s new facility. Since the trials haven’t begun, he won’t divulge details, but says they will focus on orphan drug indications, meaning they will be testing the benefits of cannabinoids on people with diseases that don’t afflict many people in the U.S. (It also means that the clinical studies are smaller – and go faster – given that fewer patients are needed for these trials.) For that reason, he said, “Big pharma companies tend not to pursue them because there’s not a big enough market for these drugs.”

Kalytera – a California-based company with a lab in northern Israel and Mechoulam on its scientific advisory board – is also focusing on orphan drug indications, conducting clinical trials at Israeli clinics and hospitals in order to bring to market a cannabinoid drug for the treatment of graft-versus-host-disease, which can happen after certain kinds of transplants.

What institutions like Kalytera and Thomas Jefferson University do is they conduct the initial phases of their clinical trials in Israel, since it’s much easier to get the process started here, and then they do the final stages in the U.S., since FDA approval requires that part of the study be done there. Once they reach the final stage (phase 3) it’s much easier to conduct the rest of their study in the U.S., because they’ve already amassed enough data to show that it’s safe. This is the ultimate goal for Kalytera, Pollack and other researchers in Israel: to speed track the process of conducting a clinical trial that meets FDA standards, thus shortening the journey toward FDA approval of their drugs.

In addition to Kalytera, Mechoulam works with two other American companies, helping them develop new cannabinoid drugs and delivery methods out of his lab in Jerusalem, where he tests the specific properties, compositions and combinations of the cannabis compounds that are best suited to alleviate a specific ailment. American companies then use that research and data to manufacture cannabinoid drugs in the U.S.

According to Saul Kaye of iCan, about 50 U.S. cannabis companies are conducting research in Israel through partnerships, joint ventures or by employing Israel-based researchers like Mechoulam. At least 15 American cannabis companies have set up their entire R&D operations on Israeli soil, conducting clinical trials, and developing the appropriate dosing forms and delivery systems for pharmaceutical-grade cannabis-based drugs. According to Michael Dor, senior medical advisor at the Health Ministry’s cannabis unit, at least 120clinicaltrials are currently underway in Israel to test the medicinal benefits of cannabis — more than any other country.

At least 15 American cannabis companies have set up their entire R&D operations on Israeli soil.

Cannabics, a Maryland-based, publicly-traded company, is conducting a clinical trial at an Israeli hospital in order to develop a capsule for cancer treatment. In 2015, One World Cannabis Pharmaceuticals, a public company based in Delaware, established an Israeli subsidiary overseen by Yehuda Baruch, the first head of the Israeli government’s medical cannabis program, established in 2007. They are now beginning phase 1 of a clinical trial to test the benefits of a topical cannabis cream to treat psoriasis. Their next trial will study the efficacy of a soluble pill for the treatment of chronic pain. They eventually plan to conduct clinical trials on patients with multiple myeloma.

Some Israeli companies have partnered with American companies to establish a presence in the U.S., where they sell products that were developed in Israel. For example, Tikun Olam, Israel’s first medical cannabis distributor, opened an American subsidiary in 2016. It now sells its proprietary medical-grade plant strains at 10 dispensaries in Delaware and Nevada and will soon be available at dispensaries in Oregon and California. Their most popular strain is Avidekel, a non-psychoactive CBD blend used to help children with seizures.

Some American researchers have even moved to Israel altogether. Alan Shackelford, a Harvard-trained physician, was among the first American doctors to prescribe cannabis to a child. His eight-year-old epileptic patient Charlotte Figi sparked national interest in CBD after her miraculous story aired on CNN’s Weed documentary in 2013.

Yet after years of failed attempts to conduct clinical trials in the U.S., Shackelford recently established his own research entity in Israel because of his frustration with the American government’s stonewalling.

“The U.S. government has funded $1.4 billion in marijuana research since 2008,” says Schackelford. “Yet $1.1 billion of that went to studying addiction, withdrawal and drug abuse,” problems that barely exist with cannabis when compared to the effects of other legal medications, like prescription painkillers, which killed more than 17,000 Americans in 2016.

His research subjects in Israel will include the development of new delivery methods, he says, “because to date, most medical cannabis products no matter where you look in the world, are pot-culture derived. They’re things like brownies, cookies, candy and smoking. Even with advances to these things being much more consistent, they’re still not medically appropriate.”

While the U.S. government restricts American cannabis companies on U.S. soil, it does not prevent them from or penalize them for conducting their work in Israel. According to Robert Farrell, president of Kalytera, “The FDA has no problem with this work being done in Israel. When you file with the FDA, in the application you say, ‘Look we’ve done the previous studies in Israel, gave the drug to this many patients, the drug is safe, it works, now we want to conduct a larger study with patients in the U.S.’ If the FDA is satisfied with the data, they’ll say, ‘Go ahead, try it in the U.S.'”

The FDA will never get behind cannabis the plant as medicine, since it can’t be controlled as a consistent drug.

Even the National Institutes of Health (NIH) has funded cannabis research in Israel. Indeed, much of Professor Mechoulam’s groundbreaking research was funded by the American government. The NIH provided him with grants to the tune of $100,000 a year for over four decades, says Mechoulam.

There is also nothing preventing Israeli companies from receiving FDA approval for their cannabis-based drugs, as long as they meet FDA requirements. In order to do so, they will need to develop the kind of products that are more in line with pharmaceutical standards, such as the kinds of capsules and inhalers BOL is developing.

While that goal is feasible, Gedo and others admit that it will take time, perhaps several years, to achieve. The process of getting FDA approval is an arduous one, especially for a drug that has long been viewed with skepticism by the medical establishment. Yet it is these clinical trials that are taking place at a record pace in Israel, along with the advancement of pharmaceutical grade cannabinoid drugs, that will enable Israeli companies to eventually receive FDA approval for their drugs, or for the drugs that they are helping American companies to develop.

As Gedo notes, the FDA will never get behind cannabis the plant as medicine, since it can’t be controlled as a consistent drug that has the same effect day in and day out. After all, there are 140 active compounds in cannabis, and the composition of the flowers plucked from one branch can fluctuate wildly, by up to 300 percent. “The experience of a user will vary a lot with the same strain,” says Gedo. “So even if you have the best-grown product, it will never become a scientific pharmaceutical product.”

This is precisely why the FDA has never approved a botanical marijuana drug, a larger problem than scheduling when it comes to drug approval. According to Senate testimony by the FDA’s Douglas Throckmorton in 2016, who was citing a report from the Institute of Medicine, in order to obtain FDA approval, drug manufacturers “must demonstrate that they are able to consistently manufacture a high-quality drug product. This is an essential part of drug development and presents special challenges when the drug is derived from a botanical source, such as marijuana…. If there is any future for marijuana as a medicine, it lies in its isolated components, the cannabinoids and their synthetic derivatives.”

BOL and other Israeli companies are working to meet that challenge by developing cannabis-based drugs – the capsules, inhalers, creams and oils composed of isolated, controlled and consistent cannabinoids. Going this route, they could eventually receive FDA approval.

While Gedo is optimistic, he’s also realistic, knowing the complexity of the FDA’s drug approval process, and the skepticism that remains among many in the medical establishment.

Still, asked when Israeli companies might be exporting their cannabis medicine to the U.S., Michael Dor, of the Israeli Health Ministry says, “I believe it’s not far.”

CHABAD

COMMENTARY: Jared Kushner Belongs To Racist Criminal Jewish Cult

Only the very ignorant or the very innocent still believe politicians are working for a better world. Even if they had the intention, they cannot do it. The powers that lead the world today are so strong that have their tentacles in every walk of life. It is revolting to learn how most succumb to their poisonous evil ways and bribes. 

In reference to the article below, we would like to add that we do not agree with the author when he says that ‘relations with Russia are less warm’. That is simply NOT the case. Putin is not only a member of Chabad Lubavitch but is strongly connected to Trump through Chabad. At the International Assembly of Chabad Representatives in 2007, Russia’s Chief Rabbi, Rabbi Berel Lazar, often referred to as “Putin’s Rabbi”, told a remarkable story about the Russian leader, which he heard from Putin himself.

CHABAD

 

“Jared Kushner Belongs to Racist Criminal Jewish Cult,” Source: henrymakow.com

Chabad came to prominence under the guidance of ‘The Great Rebbe’ Menachem Mendel Schneerson. His policies led Chabad through a period of great expansion establishing institutions in 900 cities around the world.
‘The Great Rebbe’ gave regular talks on the coming of the messiah. Over time, Lubavitchers began to realize that he meant himself. The belief that Schneerson was the Messiah was first openly professed by Rabbi Shavom Dol Wolpo in a 1984 book and quickly gained acceptance.
Absurdly, even though he died in 1994 ‘The Great Rebbe’ is still the official leader of Chabad, like ‘Great Leader’ Kim Il-Sung is the leader of North Korea.

In Chabad schoolhouses children chant and salute the invisible Rebbe.

RACIAL SUPREMACISTS

Chabad believes Jews are God’s chosen people and everyone else is trash.  In the book “Gatherings and Conversations” the Great Rebbe tells his followers that Jewish people are an extension of God and Gentiles are destined to serve the Jews.

“Two contrary types of soul exist, a non-Jewish soul comes from three satanic spheres, while the Jewish soul stems from holiness.”

“A Jew was not created as a means for some [other] purpose; he himself is the purpose, since the substance of all [divine] emanations was created only to serve the Jews.”

Rabbi Ginsburgh, a leading Chabad Rabbi, has argued that because Gentiles are genetically inferior to Jews, a Jew should be able to take Gentiles organs if he needs one. He was recorded saying, ‘As for the goyim… Zalman’s attitude (was): “Gentile souls are of a completely different and inferior order. They are totally evil, with no redeeming qualities whatsoever.”

‘If every single cell in a Jewish body entails divinity, is a part of God, then every strand of DNA is a part of God. Therefore, something is special about Jewish DNA.’

‘If a Jew needs a liver, can you take the liver of an innocent non-Jew passing by to save him? The Torah would probably permit that. Jewish life has an infinite value.’

The Jewish Daily Forward reported a talk given by Chabad Rabbi Mani Friedman.

Asked how he thinks Jews should treat their Arab neighbors Friedman responded, ‘The only way to fight a moral war is the Jewish way: Destroy their holy sites. Kill men, women and children (and cattle).’

ZIONIST APOLOGISTS

Chabad’s extremism makes them perfect apologists for Israeli crimes. A perfect example is Alan Dershowitz, a Chabad member.

Dershowitz is the premier Zionist apologist rolled out in front of the mainstream news cameras across the world to explain that Israelis are the victims of every massacre they carry out. An unhinged and creepy individual, during a recent speech he gave at Oxford University he took off his glasses and told the students that he has “Zionist eyes” as do all “reasonable people”, Dershowitz is one of many Jewish extremists in sheep’s clothing who lead mainstream political discourse in the West. 

As further evidence that Wikileaks is an intelligence operation, Dershowitz recently joined Julian Assange’s legal team.

INFLUENCE

One of the policies of the Chabad is to send Rabbis across the world to set up Chabad houses. This movement, known as shilchus, has given Chabad a global support network.

Lubavitchers mix with the upper echelons of each host country. Their influence in each country varies.

The Canadian government recently gave the cult $800,000 for the building of a Chabad center in Montreal. Relations with Russia are less warm; the Russians recently refused to hand over two major collections of Chabad texts seized by early Soviet governments.Where is Chabad’s influence the greatest? You guessed it- the US.

Rabbi Shemtov is Chabad’s Washington representative, and his enormous influence was illustrated when he lobbied successfully for the Great Rebbe to be posthumously awarded the congressional gold medal in 1995, the only religious leader ever to be given the award.

Rabbi Shemtov is an all-pervasive presence in D.C. Sue Fishkoff, author of ‘The Rebbe’s Army: Inside the World of Chabad-Lubavitch’, writes: “It’s not enough that Chabad’s man in D.C. knows the name and phone number of just about every congressman, senator and foreign ambassador in the nation’s capital — he also knows their legislative assistants, their secretaries and the people who clean their offices.”

Shemtov says that the vast network of shelichim  inside the US generates his political power. “We have shelichimin forty-seven states and in [at least] 310 districts. … People sometimes view the world of shelichim as three thousand people, but it’s not only three thousand people, it’s three thousand interconnected networks. So we can place a call from a constituent to almost any member of Congress.”

“Most shelichim have good connections with their senators, congressmen and governors, who represent the most remote places in the United States. For example, when Sarah Palin, a Republican, burst onto the scene, she had already known about Jewish issues and Chabad specifically from Rabbi Yosef Greenberg in Alaska.”

Members of the cast of ‘Friends’ recorded a piece for a Chabad telethon. Bob Dylan appeared on another.

CRIMINAL AND TERROR ENTERPRISES

Chabad is a criminal organization with ties to Mossad. Chabad houses provides safe houses and storefronts for Israeli intelligence and criminal activity. This includes everything from terrorism to money laundering, drug running to prostitution.

For instance, in March 1989 U.S. law enforcement rounded up a criminal network in Seattle, Los Angeles, New Jersey, Colombia, and Israel that involved a Chabad House that was involved in money laundering and currency violations.

Wayne Madsen writes:

‘In Bangkok, Israeli military pilots and drivers who stay at the Chabad House there train Thai Army commandos, divers, and pilots who are fighting a Muslim secessionist movement along the southern border with Malaysia.

‘Bangkok police have long suspected Chabad House as a center for the Israeli Mafia, which runs its Ecstasy and Ice trade from Bangkok for all of Southeast and East Asia. The Israeli Mafia also reportedly runs heroin labs in Myanmar, where an Israeli military officer serves in Myanmar’s feared military counter-intelligence agency.’

Retaliation against the Chabad mafia can be seen in the Mumbai terrorist attacks when Lashkar-e-Taiba militants took hostage of the Mumbai Chabad house and murdered nine Jews, including Rabbi Gavriel Holtzberg.

Wayne Madsen has reported that mafia overlord Dawood Ibrahim ordered the attacks partly in response to Israeli mafia attempts to take over his Mumbai drug trade.

‘[Wayne Madsen Report] has learned from Asian intelligence sources that the Russian-Israeli gangsters operating out of Chabad House tried to take over Mumbai’s drug trade with the help of local Jewish mobsters so Ibrahim, while settling scores with India, the CIA, and Britain, decided to have his subcontractor LET terrorists pay a visit to Chabad House and “collect on a debt with high interest.”‘

Chabad are allowed to exist as a powerful international force because they serve Israel in two ways: working with them in intelligence and criminal activities, and a source of extremist ideology to fuel Zionist crimes.

Communism - Capitol Hill

VIDEO: Important Update – Court Case, Putin Trump Predictable Cease Fire

People need to STOP supporting Trump and thinking that Putin is their savior. The lie is obvious and quite disgusting. O’Connell says it, it’s all about the drug trade, child trafficking, organ trafficking, etc. We are ruled by hardcore criminals. He also exposes Iran’s Rouhani/Rafsanjani who is in bed with the banking mafia. On this side of the world, Trump is all about Israel, while the Jews continue stealing high technology and handing it over to Russia! Russia is controlling it all, that has always been the Jews base of operations. We MUST SUPPORT Brendon O’Connell who has a real case and can legally expose it all. 

https://youtu.be/XSNYysCCG5I

this corruption in a high court. 

Israel

INTERVIEW: Zionist Agression Victim Brendon O’Connell

Brendon is one of the very few, if not the only one, who speaks out and knows exactly what is going on. It is very interesting to listen to his story. He was arrested for criticizing Israel! But he has what it takes, and decided to fight for the truth against the criminal tribe who controls it all. Money allows them to buy out the morally corrupt and threaten those in power. It takes a society of strong and determined real Patriots to bring this mafia down. 

https://youtu.be/9ND7D1K9MsE

Chabad Drug Mafia

VIDEO: Israel And Drug Smuggling

The tribe gets away with murder and why not with drug trafficking! Isn’t that one of the reasons why they went into Afganistan? Isn’t it one of their favorite money making machines besides stealing from the goyim? The drug trade is ruled by the tribe, just like everything else. And if you don’t believe us, just go to our search bar and type The Jewish Monopoly on Opium, you will find a very interesting article we posted on the history of the Opium trade. 

https://youtu.be/S-DcwtXiRtM

 

VIDEO: The CIA & The Drug Trade

The Drug Trade is what helps the Jewish banksters get access to liquid money. You must add to this, other sources of ‘cash’ such as human trafficking, extortion, and many other niceties thought of and carried out by the ‘Chosen Ones.’ That is why they have such insane amounts of money.

https://www.youtube.com/watch?v=hpPBmiO4R3E&feature=youtu.be

 

 

 

 

 

 

nicolas maduro

Vladimir Putin Awarded Peace Prize

Putin and Obama already received a Nobel Prize. Now the Nobel Prize goes to Juan Manuel Santos, President of Colombia for negotiating with the Devil alias FARC! Who is backing global economy with drug trade. What kind of world are we living in? Have people lost their power of discernment? Or is the Devil that clever that is deceiving them all? Unfortunately, we will be seeing more and more of this ‘Putin worship’ and it is a sign of the end times. Things have inverted, what was wrong and evil before is good now. World leaders are all Communists. They are working for World Dominion, they follow the law of men, which is, Talmudic Law. This is leading the world to its own destruction and those who have decided to turn a blind eye to what is really happening, are helping these sadic criminals further their agenda. 

nicolas maduro
“Vladimir Putin awarded peace prize,” Source: independent.co.uk

The president of Venezuela has created a new peace prize in honour of former socialist leader Hugo Chavez – and awarded it to Russian President Vladimir Putin.

The award was given on the same day the annual Nobel Peace Prize was presented to Juan Manuel Santos, president of neighbouring Colombia, for his role in negotiating a peace agreement with Marxist FARC rebels.

During a televised broadcast, Prime Minister Nicolas Maduro said: “I’ve decided to create the Hugo Chavez prize for peace and the sovereignty… I think President Vladimir Putin deserves this award.”

This is why the White Helmets were nominated for the Nobel Peace Prize

Describing the Russian President as a “fighter for peace”, President Maduro unveiled a statue of Chavez designed by a Russian artist for the new award.

Mr Putin and future winners will receive a miniature replica of the statue.

Speaking on air, Mr Maduro said the prize would be offered to national and international figures “who have excelled in the struggle for peace,” adding that he had chosen to honour Mr Putin with the award as he is a strong ally of Venezuela.

Hundreds of thousands of people have joined pro and anti-government demonstrations in Venezuela over the past few months. The anti-government protests are led by campaigners who criticise the government for its role in the country’s failing economy.

Mr Maduro blames the problems on an “economic war,” however, which he says has been constructed by the opposition party with help from the US government.

President Putin was nominated for the Nobel Peace Prize in 2014, despite ordering soldiers to invade Ukraine that same year. He lost to Kailash Satyarthi and Malala Yousafzai, for their work against the suppression of children and young people.

 

VIDEO: Why The Hell Are We Still In Afganistan?

Why are the United States and NATO still in Afganistan? The answer is simple: Heroin. This is how the international economy is sustained, and all world leaders are benefiting from it. 

https://www.youtube.com/watch?v=dcP_NUbBivg